AF
ALDX icon

Allworth Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Allworth Financial’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89K Sell
1,827
-258
-12% -$444 ﹤0.01% 4249
2026
Q1 		$3.52K Buy
2,085
+827
+66% +$3.62K ﹤0.01% 4142
2025
Q4 		$6.52K Sell
1,258
-504
-29% -$2.59K ﹤0.01% 3554
2025
Q3 		$9.2K Buy
1,762
+699
+66% +$3.65K ﹤0.01% 3192
2025
Q2 		$4.07K Buy
+1,063
New +$2.75K ﹤0.01% 3373

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Allworth Financial's ALDX Position: Q2 2026 in Review

Allworth Financial reduced its Aldeyra Therapeutics (ALDX) stake by 12% in Q2 2026, selling an estimated $444 and leaving 1,827 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

Allworth Financial first reported a position in ALDX in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.2K in Q3 2025. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Allworth Financial held 1,827 shares of Aldeyra Therapeutics worth $3.89K as of Q2 2026.
  • Allworth Financial sold 258 Aldeyra Therapeutics shares in Q2 2026, an estimated $444.
  • Aldeyra Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4249 holding.
  • Allworth Financial first reported a position in Aldeyra Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Allworth Financial's Aldeyra Therapeutics position peaked at $9.2K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.